Insulet (PODD) Revenue — Quarter Ended Dec 31, 2025
Revenue rose sharply in the quarter, extending a strong upward trend. Both sequential and year-over-year comparisons showed substantial growth.
Key takeaway
Quarter ended Dec 31, 2025 · FY2025 Q4
Revenue rose sharply in the quarter, extending a strong upward trend. Both sequential and year-over-year comparisons showed substantial growth.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$783.8M
Revenue reported for this quarter.
Quarter-over-quarter
+11.0%
Change from the immediately preceding quarter.
Year-over-year
+31.2%
Change from the comparable year-ago quarter.
Trailing four quarters
$2.7B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Mar 31, 2025 | $569M | +28.8% |
| Jun 30, 2025 | $649.1M | +32.9% |
| Sep 30, 2025 | $706.3M | +29.9% |
| Dec 31, 2025 | $783.8M | +31.2% |
Revenue performance
The company delivered another quarter of robust revenue expansion, building on gains from prior periods.
Quarterly comparison
Compared to the immediately preceding quarter, revenue increased at a robust pace. Versus the same quarter one year earlier, the improvement was even stronger.
What to watch
Monitor whether the revenue growth rate from the prior quarter can be sustained in upcoming periods.